COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/05/2018 - 00:00

CAMBRIDGE, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Immucor Announces FDA Clearance for Echo Lumena(TM); Next Generation, Fully Automated Instrument Powers Smaller to Mid-Volume Labs

30/04/2018 - 23:25

Faster, clearer blood compatibility results now available NORCROSS, Ga., April 30, 2018 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that its next [...]

Helix BioPharma Corp. Closes Private Placement

30/04/2018 - 23:05

RICHMOND HILL, Ontario, April 30, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP ) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Forward Pharma Reports Full-Year 2017 Financial and Operational Results

30/04/2018 - 22:40

COPENHAGEN, Denmark, April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq: FWP ) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017. Net income for the [...]

Flexion Therapeutics to Report First-Quarter 2018 Financial Results on May 8, 2018

30/04/2018 - 22:30

BURLINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced that it will report its first-quarter 2018 financial results after the close of the U.S. financial markets [...]

Portola Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018

30/04/2018 - 22:30

SOUTH SAN FRANCISCO, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) announced today that it will host a webcast and conference call to discuss the Company’s financial results [...]

Golden Leaf Reports Fiscal Year 2017 Results

30/04/2018 - 22:16

TORONTO, April 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company built around recognized brands, today announced its [...]

AzurRx BioPharma Announces Proposed Public Offering of Common Stock

30/04/2018 - 22:15

BROOKLYN, N.Y., April 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma (NASDAQ: AZRX ), (“AzurRx” or the “Company”), announced today that it intends to offer and sell shares of its common stock in an underwritten public [...]

Novartis receives FDA approval of Tafinlar® + Mekinist® for adjuvant treatment of BRAF V600-mutant melanoma

30/04/2018 - 22:11

Tafinlar + Mekinist is the first oral targeted adjuvant combination therapy to demonstrate significant clinical benefit in patients with a BRAF V600 mutation, following complete surgical resection Tafinlar + Mekinist [...]

National Brain Tumor Society Stresses Urgent Patient Needs and Experiences During Brain Tumor Awareness Month 2018

30/04/2018 - 22:06

Largest brain tumor nonprofit in the U.S. rallies supporters to raise their voices in support of the brain tumor community BOSTON, April 30, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest [...]

New Novartis Phase III data for brolucizumab demonstrate reliability of 12-week treatment interval

30/04/2018 - 22:06

Patients identified for brolucizumab 12-week treatment interval in Phase III HAWK and HARRIER trials had an 87% and 83% probability of successfully continuing on a 12-week interval through week 48 Predictability data [...]

miRagen Therapeutics to Participate in Upcoming Investor Conferences

30/04/2018 - 22:05

BOULDER, Colo., April 30, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today [...]

AxoGen, Inc. Reports 2018 First Quarter Financial Results

30/04/2018 - 22:05

Record Q1 Revenue of $17.3 million, representing 41% growth over prior year ALACHUA, Fla., April 30, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical [...]

Eloxx Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

30/04/2018 - 22:01

WALTHAM, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX ) today announced the completion of its previously announced underwritten public offering of 5,899,500 shares of its [...]

Avadel Pharmaceuticals to Present at the Deutsche Bank 43rd Annual Health Care Conference

30/04/2018 - 22:01

DUBLIN, Ireland, April 30, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL ), “Avadel” or “the Company,” today announced that Greg Divis, Chief Operating Officer, and Mike Kanan, Chief Financial [...]

Theratechnologies’ CEO and CFO to Attend Bloom Burton Healthcare Investor Conference in Toronto

30/04/2018 - 22:00

MONTREAL, April 30, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) is pleased to announce that Luc Tanguay, President and Chief Executive Officer will make a presentation at the 2018 [...]

Le chef de la direction et le chef de la direction financière assisteront à la conférence d’investisseurs Bloom Burton à Toronto

30/04/2018 - 22:00

MONTRÉAL, 30 avr. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH ) est heureuse d’annoncer que Luc Tanguay, président et chef de la direction fera une présentation dans le cadre de la [...]

Apellis Pharmaceuticals Reports First Quarter 2018 Business Update and Financial Results

30/04/2018 - 22:00

- APL-2 in Geographic Atrophy (GA) and Paroxysmal Nocturnal Hemoglobinuria (PNH) On Track to Advance into Phase 3 Trials in 2H18 - - Cash Position of $152.9 Million at Quarter-End; April 2018 Public Offering Raised [...]

New Mexico Cannabis Program on Pace to Break $100 Million

30/04/2018 - 19:47

Enrollment up 46 percent, patient sales up only 27 percent, restrictions on supply dampens sales ALBUQUERQUE, N.M., April 30, 2018 (GLOBE NEWSWIRE) -- The New Mexico Medical Cannabis Program patient revenues from the [...]